Here, we explore the importance of genomic literacy, address the hurdles stemming from lack of awareness, and outline actionable steps for stakeholders to enhance education and diversify genomic research.
Why genomic literacy matters
Genomic literacy is "the capacity to obtain, process, understand, and use genomic information for health-related decision-making." As genomics becomes embedded in clinical care, drug development, and direct-to-consumer services, this capacity is no longer optional. Patients are asked to interpret genetic test results, consent to biomarker-driven studies, and evaluate therapies targeting specific variants. Yet despite the widespread availability of information, genomic literacy remains inadequate among the general public.
Recent surveys highlight a significant knowledge gap:
- 1.2% of participants answered all basic genetic knowledge questions correctly.
- 50% of individuals are aware of genetic testing.
- 33% of individuals understand that genetic testing contributes to disease treatment.
This knowledge gap means patients are left not understanding how genetics impacts their health – and many healthcare providers are not equipped for genomics discussions. The gap also contributes to significant disparities in both research participation and access to precision medicine, especially among minority populations.
Genomics is increasingly central to how diseases are diagnosed, stratified, and treated. Inclusive genomic education provides the following benefits:
- It equips individuals to understand and act on genomic innovations as they enter clinical practice, from genetic testing to targeted therapies.
- It increases participation in genetic testing and sequencing, expanding the available data, particularly from underrepresented populations, and supporting goals such as determining normal and pathological genomic variation and facilitating personalized medicine.
- It helps prevent the widening of health disparities by ensuring that genomic discoveries reflect and benefit diverse populations.
- It empowers patients to understand their hereditary conditions and predispositions, enabling more informed decisions about their care and participation in research.
Broader population representation in genomic data is a prerequisite for precision medicine to deliver equitable clinical benefit, not only across ethnicities but across the full range of genetic variation relevant to complex disease.
Global efforts to promote genomic education
Governments, research institutions, and international organizations have launched a range of initiatives to improve genomic literacy. A review of 41 national genomic projects identified 16 that specifically described their approach to genomic education, targeting the general public, patients, and healthcare professionals through strategies such as training programs, online resources, and research collaboration.
In the UK, Health Education England's Genomics Education Programme , developed in support of the UK's 100,000 Genomes Project, offers a range of training resources including a three-week Massive Open Online Course (MOOC) on whole genome sequencing. While designed primarily to equip NHS professionals with genomic medicine skills, these resources are freely accessible to the public. This reflects a broader pattern across national genomic projects: tailoring education to specific audiences, from healthcare professionals to patients and patient organizations, through training events, online content, and research collaboration.
International entities providing genomic education include:
- World Health Organization (WHO): Offers a genomic resource centre with online tools for the general public.
- NHGRI-NIH (US): Provides a vast library of genetics education resources.
- Garvan Institute (Australia): Features a collection of videos, blogs, and factsheets.
These efforts, spanning formal educational frameworks, specialized training programs, and public-facing resources, represent meaningful progress. However, the scale of the literacy gap means that sustained investment across sectors, from government and academia to industry and clinical research, remains necessary.
Conclusion
The observed improvement in genetic literacy over the past decade, as evidenced by increased familiarity with genetic terms and concepts, shows the positive impact of current initiatives. However, persistent gaps in data representation and public awareness make clear that the work is far from complete.
The challenge extends beyond healthcare professionals. Patients, caregivers, and communities need to understand their genetic makeup and its implications for their health, their eligibility for emerging therapies, and their potential role in clinical research. As more therapies target specific genetic variants, the ability of patients to engage with genetic testing and precision medicine programs directly shapes who benefits from these advances.
For organizations involved in developing and delivering precision medicines, genomic literacy is not a peripheral concern. It is a structural factor that influences recruitment, retention, data quality, and the equity of access to new treatments. Investing in education now is essential to ensuring that the promise of genomics translates into outcomes for all populations, not just those who are already well-served.
To learn more about how Sano Genetics supports patient education and engagement in precision medicine trials, get in touch.